Grace T.
About Grace T.
Grace T. is a Therapeutic Development Specialist in Hematology at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical industry, focusing on Oncology and Hematology.
Company
Grace T. is currently working at Bristol Myers Squibb in Ontario, Canada. She holds the position of Therapeutic Development Specialist in Hematology. She began her role at Bristol Myers Squibb in January 2020 and continues to contribute to the company's efforts in therapeutic development within the hematology field.
Title
Grace T. holds the title of Therapeutic Development Specialist, Hematology. This title signifies her specialized role within Bristol Myers Squibb, where she focuses on the development of therapies aimed at treating hematological conditions.
Education and Expertise
Grace T. pursued higher education at The University of British Columbia from 1992 to 1995 and attended McMaster University. She obtained a Master's of Business Administration with an EMBA from the Kellogg-Schulich program, studied between 2005 and 2007. Her extensive educational background complements her over 20 years of experience in the pharmaceutical industry, especially in oncology and hematology.
Professional Background
Grace T. has an extensive professional background in the pharmaceutical industry, beginning her career as an Oncology Specialist at AstraZeneca Pharmaceuticals, where she worked from 1999 to 2005. She then served as a Training Consultant at Hoffmann-La Roche from 2005 to 2007, followed by a role as an Oncology Learning Specialist at sanofi-aventis Canada from 2008 to 2012. She was a Key Account Manager, Oncology, at Bayer from 2013 to 2020 before moving to her current role at Bristol Myers Squibb.
Experience in Oncology and Hematology
Grace T. has over 20 years of experience in the pharmaceutical industry, specializing in oncology and hematology. Her experience spans across various roles, including Hospital Sales and Training. Throughout her career, she has contributed significantly to the fields of oncology and hematology by working in multiple capacities at several well-known pharmaceutical companies.